Evidence map›Paper›PMID 23125875›Full record

ArticleNeuropsychiatry2012

Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention.

Neeraj Tandon, Jai Shah, Matcheri S Keshavan, Rajiv Tandon

Open access · greenAbstract read
In one paragraph

Article in Neuropsychiatry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. The Enigma of Prodromes in Hereditary Angioedema (HAE).Clinical reviews in allergy & immunology · 2021
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Attenuated psychosis syndrome in DSM-5.Schizophrenia research · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Neeraj TandonDepartment of Psychiatry, Beth Israel Deaconess Medical Center & Massachusetts Mental Health Center, Harvard Medical School, 401 Park Drive, Room 2P12, The Landmark Center, Boston, MA 02215, USA.
Jai Shah
Matcheri S Keshavan
Rajiv Tandon
Beth Israel Deaconess Medical Center · US

Funding

Stability of Biotypes: a Longitudinal EvaluationR01MH078113 · NIMH · WAYNE STATE UNIVERSITY · PI KESHAVAN, MATCHERI S. · 2007 to 2019
$6.2M
Brain Maturation and Vulnerability to SchizophreniaR01MH064023 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KESHAVAN, MATCHERI S. · 2003 to 2008
$3.0M
NIMH NIH HHS R01 MH064023NIMH NIH HHS R01 MH078113
6 · The paper itself

Abstract

Recent efforts in the prevention of schizophrenia have focused on defining psychosis-risk syndromes and evaluating treatments that can prevent transition to psychosis in these ultra-high risk groups. In this review, different kinds of prevention approaches are enumerated and necessary conditions for a disease-prevention strategy are summarized. The broad overlap as well as the significant difference between a schizophrenia prodrome and a 'psychosis-risk syndrome' is discussed and the present status of approaches to identify individuals at increased risk for developing psychosis and schizophrenia are critically examined along with evaluations on therapeutic interventions to reduce these risks. Finally, to conclude, recommendations for current best clinical practice and key questions for the future are suggested.

Identifiers

PMID23125875
PMCPMC3483069
OpenAlexW2128095909

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.